Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Cancer J
Main Authors: Ysebaert, L, Laprévotte, E, Klein, C, Quillet-Mary, A
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Letter to the Editor
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4670946/
https://ncbi.nlm.nih.gov/pubmed/26565404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.93
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki